Early stage patented NO-donating molecule

Licensing out of a novel and patented NO-donating molecule with strong inhibitory activity specifically against melanoma and breast cancer cell growth. 

• Jacobsen Pharma A/S (20/07/2010)
• MENA Oncology Conference (12/07/2010)
• The Cancer Market Outlook (23/06/2010)

• The Death Gene (24/02/2008)
• Private lubricant (25/02/2007)
• Dermatological Formulation (03/12/2006)
• Broccoli preparation (20/08/2006)
• Table Salt Substitute (11/01/2006)